Charles W Emala Selected Research

Creatinine

10/2006	A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis.
8/2005	A1 adenosine receptor knockout mice exhibit increased mortality, renal dysfunction, and hepatic injury in murine septic peritonitis.
12/2004	Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo.
1/2004	A1 adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemia-reperfusion injury in mice.
1/2004	Local anesthetics worsen renal function after ischemia-reperfusion injury in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charles W Emala Research Topics

Disease

27	Asthma (Bronchial Asthma) 08/2022 - 03/2002
18	Inflammation (Inflammations) 01/2022 - 01/2004
12	Reperfusion Injury 02/2008 - 01/2002
10	Ischemia 12/2007 - 02/2001
9	Respiratory Hypersensitivity 01/2023 - 03/2002
8	Bronchial Spasm 12/2020 - 04/2003
7	Necrosis 02/2008 - 01/2004
5	Pneumonia (Pneumonitis) 02/2022 - 01/2020
4	Brain Neoplasms (Brain Tumor) 12/2017 - 04/2007
4	Peritonitis 04/2007 - 10/2004
4	Sepsis (Septicemia) 04/2007 - 10/2004
3	Neoplasms (Cancer) 12/2017 - 12/2016
3	Glioma (Gliomas) 01/2017 - 01/2016
3	Chronic Obstructive Pulmonary Disease (COPD) 09/2013 - 06/2008
2	Infections 01/2020 - 03/2003
2	Obesity 11/2019 - 06/2005
2	Cough 01/2017 - 01/2017
2	Anaphylaxis (Anaphylactic Shock) 06/2010 - 11/2009
2	Renal Insufficiency (Renal Failure) 12/2007 - 02/2003
2	Hypersensitivity (Allergy) 12/2005 - 03/2002
1	Virus Diseases (Viral Diseases) 01/2022
1	Airway Remodeling 11/2021
1	Respiratory Insufficiency (Respiratory Failure) 12/2020
1	Cystic Fibrosis (Mucoviscidosis) 01/2020
1	Mucoepidermoid Carcinoma 01/2018

Drug/Important Bio-Agent (IBA)

8	Anesthetics (Anesthetic Agents)IBA 01/2013 - 12/2004
8	Purinergic P1 Receptors (Adenosine Receptor)IBA 12/2007 - 01/2002
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2007 - 03/2003
6	Methacholine Chloride (Methacholine)FDA Link 01/2023 - 02/2001
5	OvalbuminIBA 12/2020 - 12/2013
5	Isoflurane FDA LinkGeneric 01/2013 - 12/2004
5	CreatinineIBA 10/2006 - 01/2004
4	shogaolIBA 08/2022 - 02/2013
4	MIDD0301IBA 01/2022 - 01/2018
4	CytokinesIBA 11/2020 - 03/2003
4	Proteins (Proteins, Gene)FDA Link 11/2020 - 10/2004
4	LigandsIBA 01/2018 - 01/2012
4	Messenger RNA (mRNA)IBA 01/2013 - 02/2004
3	gingerolIBA 08/2022 - 02/2013
3	LipopolysaccharidesIBA 02/2022 - 12/2020
3	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2013 - 12/2005
3	Sevoflurane (Ultane)FDA LinkGeneric 02/2008 - 12/2004
3	Pentobarbital (Nembutal)FDA Link 09/2007 - 12/2004
3	rapacuronium (Raplon)FDA Link 12/2005 - 04/2003
2	ginger extractIBA 08/2022 - 01/2020
2	SteroidsIBA 02/2022 - 12/2020
2	Albuterol (Salbutamol)FDA LinkGeneric 02/2022 - 12/2020
2	AntigensIBA 11/2020 - 01/2020
2	Volatile Fatty AcidsIBA 01/2020 - 11/2019
2	MicellesIBA 01/2017 - 01/2016
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2017 - 12/2013
2	LeptinIBA 01/2013 - 06/2005
2	GABA-A Receptors (GABA(A) Receptor)IBA 01/2012 - 12/2008
2	gamma-Aminobutyric Acid (GABA)IBA 04/2009 - 06/2008
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 02/2008 - 01/2007
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 02/2008 - 01/2007
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 09/2007 - 04/2007
2	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 10/2006 - 02/2003
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2006 - 08/2005
2	Alanine Transaminase (SGPT)IBA 10/2006 - 08/2005
2	ChemokinesIBA 10/2006 - 08/2005
2	Neuromuscular Blocking AgentsIBA 12/2005 - 04/2003
2	Adrenergic Agents (Adrenergic Drugs)IBA 06/2005 - 06/2002
2	Adenosine Triphosphate (ATP)IBA 12/2004 - 02/2001
2	Local AnestheticsIBA 10/2004 - 01/2004
2	Peroxidase (Myeloperoxidase)IBA 10/2004 - 02/2004
2	1,3-dipropyl-8-cyclopentylxanthineIBA 02/2004 - 01/2004
1	Cysteine (L-Cysteine)FDA Link 08/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	InterferonsIBA 01/2022
1	Tamoxifen FDA LinkGeneric 01/2022
1	MelatoninIBA 12/2021
1	AllergensIBA 12/2020
1	Fluticasone (Cutivate)FDA LinkGeneric 12/2020
1	Interferon-gamma (Interferon, gamma)IBA 12/2020
1	GelsolinIBA 11/2020
1	SphingolipidsIBA 11/2020
1	Chemotactic FactorsIBA 11/2020
1	(3,4,5- trimethoxy- N- (2- methoxyethyl)- N- (4- phenyl- 2- thiazolyl)benzamideIBA 01/2020
1	Acetates (Acetic Acid Esters)FDA Link 01/2020
1	BenzbromaroneIBA 01/2020
1	Bile Acids and Salts (Bile Acids)IBA 01/2020
1	Butyrates (Butyrate)IBA 01/2020
1	PropionatesIBA 01/2020
1	AdipokinesIBA 11/2019
1	Nonesterified Fatty Acids (NEFA)IBA 11/2019
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 01/2018
1	Fluorescein (Funduscein)FDA LinkGeneric 12/2017
1	Trans-Activators (Trans-Acting Factor)IBA 12/2017
1	Cell-Penetrating PeptidesIBA 12/2017
1	IsotopesIBA 01/2017
1	Irritants (Vesicants)IBA 01/2017

Therapy/Procedure

13	Therapeutics 11/2021 - 07/2006
6	Anesthesia 01/2013 - 12/2004
3	Punctures 04/2007 - 10/2004
3	Ligation 04/2007 - 10/2004
2	Oral Administration 01/2022 - 01/2018
2	Injections 12/2017 - 12/2004
2	Drug Therapy (Chemotherapy) 12/2017 - 04/2007
2	Intra-Arterial Injections 01/2017 - 01/2016